AptarGroup Community
NYSE:ATR Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 6 Analysts
Injectables Expansion And Probiotics Demand Will Drive Future Success
Key Takeaways AptarGroup's Pharma segment growth driven by drug delivery systems and emergency medicines is expected to significantly boost revenue and earnings. Strategic capacity expansions and innovation across segments enhance revenue potential and improve profit margins through operational efficiencies.
View narrativeUS$177.00
FV
15.0% undervalued intrinsic discount5.04%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Updated narrative